Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03573206 · ClinicalTrials.gov registry record · NA

AMBULATE Continued Access Protocol to Evaluate the Cardiva Mid-Bore Venous Vascular Closure System (VVCS)

A NA study of Surgical Wound, sponsored by Cardiva Medical.

Completed
Registry status
NA
Development phase
168
Enrollment target
3
Study locations

NCT03573206: Completed NA study of Surgical Wound, sponsored by Cardiva Medical.

NCT03573206 is a NA study of Surgical Wound that has completed, run by Cardiva Medical. The registered enrollment target is 168 participants, above the 86-participant average among 17 other Surgical Wound trials with a reported enrollment target (95% higher). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03573206, a NA study of Surgical Wound, has completed, sponsored by Cardiva Medical.

COMPLETED
Registry status
NA
Development phase
168 participants
Enrollment target
3
Study locations

Study Summary

The objective of the trial is to demonstrate the safety and effectiveness of the Cardiva Mid-Bore Venous Vascular Closure System (VVCS) in sealing femoral venous access sites at the completion of catheter-based procedures performed through 6-12 Fr introducer sheath, while allowing for one or more of the following: elimination of the Foley catheter, elimination of protamine, or allowing same (calendar) day discharge for the appropriate patient population.

Primary Outcome

Final hemostasis at all venous access sites and freedom from major venous access site closure-related complications through 30 days follow-up

Conditions Studied

Interventions

  • DEVICE Cardiva Mid-Bore Venous Vascular Closure Device (VVCS)

Study Locations (3)

Georgia

  • Emory St. Joseph's Hospital - Atlanta

New Jersey

  • Valley Hospital - Ridgewood

Texas

  • Texas Cardiac Arrhythmia Research Foundation - Austin

Trial Details

FieldValue
Enrollment Target 168 participants
Start Date 2018-08-27
Est. Completion 2019-03-31
Phase NA
Cardiva Medical

5 total trials

What the finished NCT03573206 record still lists

NCT03573206 is an interventional study that assigns participants to a tested intervention. The registered 168 participants enrollment target is mid-sized for trials with a published cap, above the 86-participant average among 17 other Surgical Wound trials with a reported enrollment target (95% higher).

The record links to 1 condition, with Surgical Wound appearing as the primary indexed condition, and to 1 intervention - of which Cardiva Mid-Bore Venous Vascular Closure Device (VVCS) is the first listed.

NCT03573206 reports a single indexed study location in Georgia, New Jersey, Texas.

Frequently Asked Questions

What is clinical trial NCT03573206 about?

NCT03573206 is a clinical study titled "AMBULATE Continued Access Protocol to Evaluate the Cardiva Mid-Bore Venous Vascular Closure System (VVCS)". The objective of the trial is to demonstrate the safety and effectiveness of the Cardiva Mid-Bore Venous Vascular Closure System (VVCS) in sealing femoral venous access sites at the completion of catheter-based procedures performed through 6-12 Fr introducer sheath, while allowing for one or more of...

What is the current status of trial NCT03573206?

This trial is currently completed. It is a NA study. The enrollment target is 168 participants. The study started on 2018-08-27. Estimated completion is 2019-03-31.

What conditions does trial NCT03573206 study?

This clinical trial studies the following conditions: Surgical Wound.

What interventions are being tested in trial NCT03573206?

The interventions under investigation include: Cardiva Mid-Bore Venous Vascular Closure Device (VVCS) (DEVICE).

Who is sponsoring clinical trial NCT03573206?

This trial is sponsored by Cardiva Medical, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03573206 being conducted?

This trial has 3 study locations across Georgia, New Jersey, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Surgical Wound

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03573206's enrollment target sits among peer trials

168 3rd of 17 higher than 15 of 17 other Surgical Wound trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Surgical Wound trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02118922 · 168 participants

    A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia

  • NCT03536897 · 168 participants

    IORT Following Breast Conserving Surgery for Early Stage Breast Cancer Registry

  • NCT04078230 · 168 participants · NA

    Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma

  • NCT04159168 · 168 participants · NA

    Facial Affect Sensitivity Training for Young Children With Callous-unemotional Traits

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03573206, the US trial registry maintained by the National Library of Medicine. NCT03573206 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.